Skip to content

Clinical trials

Hepatitis B trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: New Zealand Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20071
20081
20124
20131
20143
20152
20162
20172
20188
20203
20217
20222
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated10
Active, not recruiting3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences10
Assembly Biosciences8
GlaxoSmithKline4
Vir Biotechnology, Inc.4
Alios Biopharma Inc.3
Arrowhead Pharmaceuticals3
Aligos Therapeutics1
Alnylam Pharmaceuticals1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B47
Hepatitis B, Chronic31
Hepatitis9
Hepatitis D2
Hepatitis, Chronic2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.